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A singular feature of adult diﬀerentiated hepatocytes is their capacity to proliferate allowing liver regeneration. This review
emphasizes the literature published over the last 20 years that established the most important pathways regulating the hepatocyte
cell cycle. Our article also aimed at illustrating that many discoveries in this field benefited from the combined use of in vivomodels
of liver regeneration and in vitromodels of primary cultures of human and rodent hepatocytes. Using these models, our laboratory
has contributed to decipher the diﬀerent steps of the progression into the G1 phase and the commitment to S phase of proliferating
hepatocytes. We identified the mitogen dependent restriction point located at the two-thirds of the G1 phase and the concomitant
expression and activation of both Cdk1 and Cdk2 at the G1/S transition. Furthermore, we demonstrated that these two Cdks
contribute to the DNA replication. Finally, we provided strong evidences that Cdk1 expression and activation is correlated to
extracellular matrix degradation upon stimulation by the pro-inflammatory cytokine TNFα leading to the identification of a new
signaling pathway regulating Cdk1 expression at the G1/S transition. It also further confirms the well-orchestrated regulation of
liver regeneration via multiple extracellular signals and pathways.
1. Introduction
The cell cycle is highly conserved cellular process allowing
a cell to divide in two identical daughter cells. Although
mammalian cells show a higher degree of complexity, the
molecular pathways controlling the progression throughout
the cell cycle and both DNA replication and mitosis are
relatively well conserved among eukaryotic cells [1]. The
most conserved pathways of the cell cycle are probably DNA
replication and major check-points for DNA integrity and
mitosis. In contrast, more specific pathways control the
transition from quiescence to DNA replication in eukaryotic
organisms. In mammalian cells, specific combinations of
extracellular signal stimuli induce the exit from quiescence,
progression throughout G1 phase, and commitment to DNA
replication. Proliferation stimuli include a vast superfamily
of growth factors and cytokines activating downstream
intracellular signaling pathways mainly through a cascade
of phosphorylation and dephosphorylation events that ulti-
mately triggers changes in gene expression in order to induce
the proteins required for duplication of cellular components
including DNA and the subsequent mitosis [2]. Among
these protein kinases, the sequential activation of the cyclin-
dependent kinases (Cdks) has been extensively characterized
and plays a crucial role in regulating the entry into and
progression through the cell cycle [3].
The discovery of the first Cdk, Cdk1 initially named cdc2
in yeast, has opened a large field of research leading to the
identification of many cell cycle regulators and the pathways
they are involved into. The first studies regarding the cell
cycle regulation were conducted using cell models such as
yeasts and oocytes from amphibians and marine organisms
that synchronously progress throughout the diﬀerent phases
of the cell cycle in order to analyze expression and activation
of regulators at each step of the cell cycle. From the mid-
1970s to the late 1980s, the burst of data obtained in these
eukaryotic cells leads to the identification of major cell
cycle regulators including the cyclins [4] and their catalytic
subunit partners the Cdks [3]. Mammalian homologs of
these cell cycle regulators were subsequently isolated and by
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Figure 1: Sections of mouse liver evidencing detection of DNA replication and G2 phase. Mice were hepatectomized, injected at 46 hours
after hepatectomy with BrdU, and killed 2 hours later (at 48 h). Livers were fixed for histological studies and detection of BrdU to visualize
hepatocytes replicating DNA (a) or phosphohistone H3 (b) to detect cells in G2 phase. (a) This lowmagnification picture shows the detection
of BrdU positive cells replicating DNA, illustrating that replicating hepatocytes are initially localized in the vicinity of the portal vein while
around centrolobular veins (CV) only few hepatocytes replicate DNA at 48 h. (b) A higher magnification picture shows nuclei of hepatocytes
reaching G2 phase (detection of phosphohistone H3 positive cells with punctuated nuclear signal: G2 and mitosis (M). Bars: 100 μm.
the mid-1990s a network of Cdk/cyclin complexes emerged
opening a complete new field in cancer research since many
of these cell cycle regulators are altered during oncogenesis
and/or are potential therapeutic targets for cancer treatments
[5].
In vivo, cell renewal is mainly achieved through the
proliferation of adult stem and progenitor cells that prolif-
erate actively although these cells can probably arrest in G0
before additional rounds of division or entering a program
of diﬀerentiation. Because progenitor cells are rare cells and
cannot be easily purified, there are few data regarding cell
cycle regulation in these cell types. There are, however, adult
diﬀerentiated cell types that remain arrested in G0, which
can reenter the cell cycle for several rounds of division upon
appropriate proliferation stimuli including lymphocytes [6]
and fibroblasts [2] which can be isolated relatively easily
from blood or skin, respectively, plated in culture and
used for cell cycle studies. Although these cell types are
suitable models for conducting cell cycle studies, there have
been a limited number of publications reporting cell cycle
data using lymphocytes and mainly because these primary
cells need to be renewed for each experiment. The most
widely used cell models in the field of cell cycle regulation
are the immortalized or transformed cell lines artificially
synchronized by drug treatments arresting the cells in G1/S
or G2/M transitions and the primary fibroblasts arrested by
serum starvation in a G0-like state. Although the scoop of
this paper is to focus on the progression in late G1 and
the G1/S transition, it is important to point out that the
comparison between these in vitro models of G0-like or
early G1 arrest and in vivo G0 arrested cells was poorly
documented formany years. However, recent reports evinced
diﬀerences between “arrested” cells in various conditions
[7, 8]. For instance, the serum starvation of fibroblasts plated
at low density obviously provides an experimental condition
completely diﬀerent from G0-arrested cells in vivo, which
stop dividing for other reasons than the lack of growth
factors or nutrients. Nevertheless, these in vitro synchronized
mammalian cells provided powerful models to investigate
cell cycle in mammalian cells and allowed to collect crucial
data on the progression from early G1 to the commitment to
DNA synthesis.
In mammals, synchronized cell proliferation in vivo is
restricted to very few cell types among which proliferation
of hepatocytes during liver regeneration following partial
hepatectomy has probably been the most used model. In this
paper, we will focus on the peculiar regulation of the Cdk1
expression and activation during the hepatocyte cell cycle.
2. In Vivo and In Vitro Models of Synchronized
Hepatocyte Proliferation
In contrast to other regenerating tissue, the liver regenera-
tion process involves massive proliferation of diﬀerentiated
hepatocytes in the remnant tissue (Figure 1). The liver
regeneration is triggered experimentally by liver resection
or by injection of hepatotoxic agent leading to cell death
either by necrosis or apoptosis such as the thioacetamide [9]
or CCl4 [10]. However, the most commonly used model of
liver regeneration is the partial hepatectomy in rat or mouse.
After 2/3 hepatectomy, liver regeneration begins with a first
synchronous wave of hepatocyte proliferation, followed by
sequential proliferation of biliary, kupﬀer, and endothelial
cells [11, 12]. Proliferation of mature hepatocyte first occurs
within the parenchyma in the vicinity of the portal triads
and proceeds to the pericentral area close to the centolobular
veins [13] (Figure 1). The unique ability of diﬀerentiated
hepatic cells to exit from quiescence and reenter the cell
cycle after a tissue loss has aroused numerous studies to
identify exogenous factors triggering the liver regeneration
and regulators of hepatocyte cell cycle progression. Both in
vivo and in vitro models have been extensively studied for
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identifications of the extracellular stimuli regulating cell cycle
of mature hepatocytes and downstream signaling pathways.
Using in vivo models, Molten and Bucher have shown
that circulating growth factors present in the serum of hepa-
tectomized rats induce hepatocyte replication in parabiosed
nonhepatectomized animals [14]. Using primary culture of
rat hepatocytes, HGF, TGFα, EGF, heparin-binding EGF-
like growth factor (HB-EGF), and amphiregulin have been
identified as potent hepatocyte growth factors [12]. However,
the injection in rat of these growth factors does not
induce massive hepatocyte DNA replication since normal
hepatocytes in vivo are not able to respond to mitogenic
signal without priming events allowing hepatocytes to
become “sensitive” to growth factors. The proinflammatory
cytokines TNFα and IL-6 are the early stimulus during
the liver regeneration allowing the exit of hepatocytes from
quiescence and the priming of hepatocytes [15, 16]. Rapid
induction of urokinase activity and urokinase receptor
expression appeared within 5min followed within 30min by
a rapid activation of NFkB and STAT3. These transcription
factors participate to the induction of a subset of genes called
“immediate early genes” including c-fos and c-Jun leading to
an increase in AP1 activity.
Then high levels of HGF are found in plasma around two
hours after PH. This initiation phase controlled by proin-
flammatory cytokines thus results in the G0/G1 transition
and early G1 progression allowing hepatocytes to become
sensitive to growth factors and competent for commitment
to DNA replication. Therefore, the complex regenerating
process is now divided in three distinct phases: the initiation,
proliferation, and termination steps. In rat and, to a lesser
extent, in mouse the first wave of hepatocyte proliferation
following partial hepatectomy (PH) is synchronous. In both
rat and mouse, within less than 15 minutes after the PH,
hepatocytes exit quiescence and enter in G1-phase [17]. The
timing of DNA replication and mitosis is however diﬀerent
between the two species. The peak of DNA synthesis is
observed at 22–24 h in rat followed by a peak of mitosis at
28–30 h [18–22] while DNA replication occurs nearly 24 h
later in mice. Seven days later, the liver has recovered nearly
70% of its initial mass.
Isolation of hepatocytes from rodent and human liver
and establishment of in vitro culture systems have pro-
vided powerful experimental in vitro models to identify
extracellular signals and to study intracellular signaling
pathways regulating diﬀerentiation and controlling the ratio
between proliferation and apoptosis in liver. Enzymatic
liver dissociation triggers G0/G1 transition of quiescent
hepatocytes, which progress up to and arrest in mid-G1
phase in absence of growth factors in primary culture
[23, 24]. It has been proposed that rupture of cell-cell
interactions [23] and induction of oxidative stress [25] or
proinflammatory response [26] during liver dissociation
could be responsible of hepatocytes reentry into the cell cycle,
mimicking the eﬀect of proinflammatory cytokines TNFα
and IL6 which control the G0/G1 transition in vivo during
liver regeneration [11, 27]. In agreement, we demonstrated
that TNFα was released into the perfusion buﬀers during
the in situ procedure of hepatocyte isolation by collagenase
dissociation of the rat and mouse liver with various amounts
ranging from 100 to 500 pg/mL (Corlu A and Loyer P,
unpublished data).
In pure culture of hepatocytes, expression of liver specific
functions progressively decreases and apoptosis eventually
occurs within a week through the activation of caspases
3, 8, and 9 in hepatocytes [28–30]. Nevertheless, this in
vitro culture model has been very useful to identify survival
factors and mitogens based on their ability to induce DNA
replication. In pure culture of rat hepatocytes, addition
of 25 ng/mL of EGF in the culture induces a robust and
partially synchronized DNA replication followed by the
mitosis (Figure 2). Using this synchronous primary model,
our laboratory and others investigated cell cycle regulation
Cdk/cyclin expressions and activations [12, 31–33].
More recently, we used a coculture model associating rat
hepatocytes with rat liver epithelial cells (RLEC also called
BEC for biliary epithelial cells), in which heterotypic cell-
cell contacts are restored and a spontaneous early production
and deposition of extracellular matrix are observed [34–
36]. This coculture model (Figure 3) compared to the pure
culture of hepatocytes exhibits numerous advantages: adult
hepatocytes remain highly diﬀerentiated for several weeks
[37] and are unable to proliferate under EGF or HGF
stimulation alone as in liver tissue [38]. Therefore, based
on the data obtained in vivo, we successfully designed a
stimulation procedure allowing multiple hepatocyte division
cycles without loss of diﬀerentiation [39]. In this coculture
system, diﬀerentiated and quiescent hepatocytes are able to
proliferate under costimulation with TNFα and EGF or HGF.
This co-stimulation with TNFα and EGF leads to pro-
liferation of nearly all the hepatocytes over a week [39].
Three days after TNFα/EGF or TNFα/HGF stimulation, at
least 35% of hepatocytes divide whereas no DNA synthesis is
observed in presence of HGF or EGF alone. Both mono- and
binuclear hepatocytes progressed up tomitosis and cytokine-
sis allowing the significant expansion of hepatocyte colonies.
These results are in agreement with in vivo experiments,
in which coinjection of TNFα and growth factors induced
hepatocyte proliferation in absence of partial hepatectomy
[15]. Moreover, TNFα alone did not induce hepatocyte
proliferation in coculture as observed in vivo [15] and in
long-term DMSO cultures [40]. Remarkably, hepatocytes
gradually stop synthesizing DNA even under prolonged
TNFα/EGF stimulation. We demonstrated that a cell cycle
arrest following the first wave of divisions is essential for
inducing a second round of proliferation. Although cells do
not proliferate in a synchronous manner in this coculture
model, this in vitro cell system mimics the behavior of the
hepatocytes in the whole liver and was used to investigate the
involvement of cell-cell and cell-matrix interactions in the
regulation of the hepatocyte cell cycle.
3. The G1 Phase and the Mitogen-Dependent
Cell Cycle Progression
Nearly three decades ago, the in vitro synchronized fibrob-
lasts allowed to distinguish diﬀerent steps in the G1 phase
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Figure 2: Proliferation of rat hepatocytes in pure culture. Isolated rat hepatocytes (right, picture in phase contrast) seeded at low
density (<5.104 cells/cm2) and stimulated with EGF (25 ng/mL) commit to DNA synthesis (BrdU incorporation, histogram and in situ
immunodetection of BrdU positive cells) and complete the cell cycle (mitotic index, right axis). Western blotting of Cdk1 and Cdk2 and the
loading control Hsc70.
progression and to define the concept of “restriction point”
[41]. The progression through the G1 phase can be divided
in several periods, which are diﬀerent between cell types. For
instance, the progression of fibroblasts throughout G1 could
be divided in 4 periods: competence, entry, progression, and
assembly (Figure 4). The stimulation of starved fibroblasts by
PDGF promotes progression in early G1 until the restriction
point C, defining the so-called competence, but fails to
allow progression in mid- and late G1 [42–45]. Then the
progression in late G1 and S phase can be achieved by subse-
quent stimulation with EGF or insulin [46, 47]. However, in
absence of essential amino acids, cells arrest in mid-G1 at a
restriction point named “V.” The progression between points
“C” and “V “defines the period called entry [48] while the
progression between point “V” and the mitogen-dependent
restriction point (point “R”) is called progression. Finally,
the period beyond the mitogen-dependent restriction point
and before the burst of DNA synthesis is named assembly
[49]. A minimal period of stimulation is required to reach
the late G1 and, beyond this point, the cell cycle is completed
even after removing growth factors. This restriction point
is very similar to the start point in yeast that controls the
commitment to S phase [50]. It is essential to distinguish
the G1 progression between cells that proliferate actively and
enter G1 after completion of mitosis and cells reentering the
cell cycle after a prolonged quiescence or G0. The transition
from G0 to G1 is characterized by a profound modification
of the expressed gene profile [2] required for metabolic
adaptation to cell proliferation and resulting in a longer
period of time for the cells to initiate progression in late G1
compared to the cells exiting mitosis.
Primary cultures of rat and mouse hepatocytes were
widely used to analyze hepatocyte cell cycle entry and
progression through the G1 phase. Our group has shown that
during cell isolation rat hepatocytes expressed immediate
early protooncogenes such as c-fos and c-myc suggesting
a “spontaneous” G0/G1 transition following cell-cell inter-
action destruction [23]. On the other hand, it had been
also demonstrated that rat hepatocytes in pure culture
undergo DNA replication when they were stimulated by
growth factors alone [51, 52]. Thus, we hypothesized that
hepatocytes were arrested in G1 phase in absence of growth
factors and that by comparing unstimulated and stimulated
hepatocyte it should be possible to characterize the diﬀerent
steps of G1 phase in hepatocytes [24]. Confirmation that
collagenase perfusion of the liver induces the G0/G1 transi-
tion of quiescent normal rat hepatocytes was provided and
we showed that progression in late G1 triggers hepatocyte
ability to respond to growth factor alone. Importantly,
demonstration that hepatocytes are able to progress from
an early G1 to a mitogen-dependent restriction point (R
point) located to mid-late G1 was shown (Figure 5). Indeed,
in absence of growth factor and serum, hepatocytes are
able to progress up to mid-late G1 phase as shown by the
sequential overexpression of c-fos, c-jun, c-myc, jun D and
then c-Ki-ras and p53. In addition, low levels of cyclin
D1 and D2 are observed while cyclin A and Cdk1 are not
expressed. Moreover, the progression towards the G1/S is
strictly dependent upon the stimulation by growth factor.
To further demonstrate the mitogen-dependent restriction
point, we hypothesized that if the addition of EGF was
performed at any time point before cells had reached the
R point, the onset of DNA synthesis would not be aﬀected.
In contrast, if the addition of EGF occurred after cells had
reached the R point, a delay in the onset of DNA synthesis
should be observed. The hypothesis was experimentally
confirmed: when addition of EGF occurred at diﬀerent times
but prior to 42 h after hepatocyte seeding, DNA replication
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Figure 3: Proliferation of rat hepatocytes in coculture. Upper left:
phase contrast picture of a colony of rat hepatocytes surrounded by
Rat Liver Epithelia Cells (RLECs). Upper right: indirect immunode-
tection of BrdU positive hepatocytes evidencing DNA replication
within the hepatocyte colony. Chart: multiple waves of replication
in hepatocytes maintained in coculture over 52 days. Four periods
of stimulation using EGF and TNFα (E/T) were separated by
culturing the cells in basal medium lacking the mitogenic cocktail.
The BrdU was incorporated for 24 h and at each time point
triplicate cultures were fixed and stained for BrdU detection.
took place at the same time (48–60 h) while for delayed
stimulations the onset of DNA synthesis was postponed
(Figure 5). A lag phase between the R point and the onset
of the DNA synthesis appeared to be approximately 12–18 h.
In this hepatocyte primary culture, Cdk2 mRNA is
detectable throughout the G1 phase but significantly
increased after the EGF stimulation. Cyclin A is detected at
the entry of S phase and Cdk1- and Cdk2- dependent histone
H1 kinase activity is mainly detected in S andMphases.Weak
levels of cyclin E mRNA are found in unstimulated cultures,
but levels of this mRNA greatly increased after growth
factor stimulation. Surprisingly, cyclin D3 mRNAs appear to
accumulate in absence of EGF stimulation whereas a drastic
increase in cyclin D1 expression accompanies the R point
overcrossing. The cyclin D1 mRNA accumulation correlates
with the R point onset and the cyclin D1 protein is detected
10–15 h later. In accordance with these observations, accu-
mulation of cyclin D1 is also detected when the hepatocytes
are stimulated by HGF [53]. Importantly, if progression
beyond the restriction is delayed by late EGF stimulation,
cyclin D1 induction is postponed accordingly demonstrating
that cyclin D1 induction is essential for cell cycle progression
at the mitogen-dependent restriction point.
The question arises whether this restriction point existed
in vivo. Nicely, a growth factor dependency in mid-late
G1 phase of proliferating rat hepatocytes in vivo was also
observed [54]. To reach that conclusion, we first analyzed
the expression of cyclin D1 during liver regeneration and
showed its induction at 12 h after hepatectomy, which is a
time coinciding with the 2/3 of G1 progression as previously
shown in primary culture of rat hepatocytes.We next isolated
rat hepatocytes isolated 5, 7, 9, 12, or 15 h after PH and
showed that only those isolated from 12–15 h regenerating
livers were able to replicate DNA without growth factor
stimulation.Moreover, intravenous administration of aMEK
inhibitor (PD98059) in vivo, before MEK activation at 10.5 h
post-PH, was able to inhibit cyclin D1 mRNA accumula-
tion and hepatocyte DNA replication demonstrating that
MEK/ERK signaling pathway was involved in cyclin D1
induction and R point overcrossing. To the best of our
knowledge, these data provide the unique evidence that the
mitogen-dependent restriction point identified in cultured
hepatocytes exists in vivo in whole organs and animals.
These results were strengthened by Albrecht’s observations
showing that transient enforced expression of cyclin D1 in
hepatocytes stimulates assembly of active cyclin D1/cdk4
complexes, robust hepatocyte proliferation, and liver growth
in rat liver [55]. However, in this in vivo model, after
several days, hepatocyte proliferation is inhibited despite
the persistence of high levels of cyclin D1 and cyclin E,
suggesting that antiproliferative response related to marked
upregulation of p21Cip1 represses cyclin D1/cdk4- and cyclin
E/cdk2-dependent kinase activities. More recently, using
mice carrying a floxed EGFR allele to inactive the EGF
receptor, Natarajan et al. [56] observed delayed liver regen-
eration characterized by defective G1/S phase entry, reduced
cyclin D1 expression followed by moderate Cdk2 and Cdk1
expression. In parallel, these authors reported an increased
mortality after PH associated to high levels of TNFα in the
serum. They also suggested that soluble TNFα, which is a
priming agent for hepatocytes, was produced at high levels
by liver cells to compensate cell cycle arrest with a subsequent
induction of cell death in absence of proliferation.
Similar studies were performed in many other cell mod-
els leading to the conclusion that in all cell types the G1 phase
could be divided in subphases corresponding to major steps
in the metabolic adaptation required for cells to replicate
DNA and divide. However, for each cell types, specific growth
factors and signaling pathways are involved. Among the solu-
ble factors inducing proliferation, the “priming” factors pro-
mote in early G1 while combination of cytokines and growth
factors stimulates progression in late G1 and the G1/S tran-
sition. Then, following binding to their receptors, priming
and growth factors activate multiple phosphorylation events
involving multiple protein kinases especially the MAPKinase
pathways [57, 58]. Moreover, multiple crosstalks between
these pathways exist and lead ultimately to the activation of
transcription factors that sequentially trigger induction of
cell cycle regulators such as the cyclins and Cdks.
4. The Cell Cycle Is Regulated
through the Sequential Activation of
Cdk/Cyclin Complexes
Progression of eukaryotic cells through the cell cycle is
regulated by the sequential formation, activation, and sub-
sequent inactivation of structurally related serine/threonine
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Figure 4: Progression through the G1 phase is divided into several subphases. Photographs illustrate detection of cells in G2, M, G1,
and S phases: the cells were stained with DAPI (DNA) and indirect immunofluorescence detection of γ-tubulin in centrioles was used
to discriminate between cells in G1 phase (a single centrosome), S phase (two centrosomes side by side), G2 (two centrioles on each side of
the nucleus), andM (centrioles pulling apart the chromosomes). Four steps were identified during the G1 phase of the cell cycle: competence,
entry, progression, and assembly.
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Figure 5: Evidencing the R point in primary rat hepatocytes. In
absence of EGF rat hepatocytes do not replicate DNA. However,
they sequentially express early G1 phasemarkers strongly suggesting
a cell cycle arrest in midlate G1 phase. The mitogen-dependent
restriction point was localized by performing stimulation with EGF
at diﬀerent time points (24, 36, 42, 48, 54 h) after seeding the hep-
atocytes. Then the DNA replication was monitored by measuring
the incorporation of radiolabelled thymidine into the hepatocyte
DNA. For stimulations between 24 and 42 h, DNA replication began
between 48 and 54 h. When cells were stimulated at 48 or 54 h,
DNA replication was significantly delayed demonstrating that the
progression in G1 phase regardless of stimulation by EGF ended
around 42 h and that the progression beyond this point required
a mitogenic stimulation.
protein kinases, the cyclin-dependent kinase or Cdks. In
mammalian cells at least 20 Cdks, 5 Cdk-like protein kinases
[3], and more than 30 cyclins have been identified which
formmultiple Cdk/cyclin complexes controlling the cell cycle
progression [59] and regulating gene transcription and RNA
processing [60]. Cdks become active upon binding to their
regulatory and periodically expressed subunits, namely, the
cyclins. Timing of activation of these complexes is deter-
mined by a variety of mechanisms including transcriptional
regulation, formation of complexes between Cdks, cyclins
and other regulatory partners such as Cdk inhibitors (Cdki).
In addition, phosphorylation, subcellular localization, and
selective proteolysis regulate the catalytic activity of these
complexes.
For many years, the G0/G1 transition and progression
in early G1 phase was thought to occur in a Cdk/cyclin
independent manner. Following stimulation by priming fac-
tors, immediate early genes are induced at a transcriptional
level by preexisting latent transcription factors such as NF-κB
[61]. While cells leave quiescence to enter G1, the phospho-
rylation level of pocket protein family members varies [62]
and inactivation of pRb is shown suﬃcient to induce G0/G1
transition in quiescent cells [63]. Ren and Rollins postulated
that hypophosphorylated or unphosphorylated pRb present
in glioblastoma T98G0-arrested cells may be phosphorylated
by Cdk3/cyclin C complexes to promote entry into G1
phase [64]. However, most cells lack functional Cdk3 and
no conclusive data on the ubiquitous role of Cdk3/cyclin
C complex at the G0/G1 transition have been drawn. More
recently, it was reported that Cdk2 interacts with cyclin
C in early G1 [65, 66] to phosphorylate the transcription
factor LSF (late simian virus 40 factor) [67]. Phosphorylation
of LSF on serine 291 by the MEK/extracellular signal-
regulated kinase (ERK) signaling pathway upon stimulation
by growth factors [58, 68, 69] in mid-late G1 phase is
essential for the G1/S transition since phospho(S291)-LSF
controls the transcriptional activation of the thymidylate
synthase (Tyms) [70]. In contrast, phosphorylation of LSF
on serine 309 inhibits LSF transactivation suggesting the
required LSF shutdown in early G1 and its reactivation in late
G1 mediated by Cdk/cyclin complexes and ERK, respectively
[65]. This work appears important because it suggests a
possible involvement of Cdk/cyclin complexes in early G1
and identifies LSF as the second known phosphorylation
substrates of Cdk/cyclin complexes, in addition to pRb, dur-
ing progression from quiescence to late G1 phase (Figure 6).
The signaling pathways essential for the subsequent
progression in late G1 are much more documented and
clearly involve the Cdk/cyclin complexes [71]. The transition
from mid- to late G1 phase is regulated by sequential
phosphorylation events of members of the pocket protein
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family including the retinoblastoma protein (pRb), p107,
and p130 [62] by Cdk/cyclin complexes [4, 72]. In mid-
G1, the hypophosphorylated pRb is bound to the tran-
scription factor E2F family members thereby preventing
active transcription of E2F-regulated genes. The negative
regulation of E2F transcription factors mediated by pRb
occurs through a conformation structure that prevents
E2F’s transactivation domain to be active and probably
also by recruiting chromatin-modifying enzymes repressing
transcription [73]. Upon stimulation by growth factors,
D-type cyclins are upregulated [74] and associate with
Cdk4 and/or Cdk6 to form active complexes [75, 76] that
partially phosphorylate pRb and/or actively phosphorylate a
fraction of pRb [72]. In late G1, formation of Cdk2/cyclin
E complex triggers additional phosphorylation of pRb to
generate the hyperphosphorylated form of pRb (Figure 6)
that loses the ability to repress the transactivation domain of
E2F’s factors [77]. Consequently, the release of E2F proteins
promotes transcription of a large set of genes required for the
progression in late G1 including Cdk2 and cyclin E [78, 79],
S phase entry [80–82] and centrosome duplication [83]. In
parallel, Cdk2 phosphorylates the nuclear protein ataxia-
telangiectasia implicated in the transcription of histones
[84] and the nucleophosmin/B23 regulating centrosome
duplication [85]. At this stage of the cell cycle progression
cells have committed to DNA replication. Thus, turning
on the E2F-dependent transcription coincides with the
progression beyond the mitogen-dependent restriction point
identified by Pardee and coworkers [49] before the discovery
of Cdk/cyclin complexes.
Importantly, single or combined genetic alterations in
mice of Cdk4/6-Cyclin D, Cdk2-Cyclin E, p27Kip1, and
Rb do not aﬀect early embryogenesis highlighting multiple
compensatory mechanisms and overlapping role of these
genes introducing the notion of redundancy and flexibility
of the cyclin/cdks [86, 87] The analysis of the cell cycle
in MEFs derived from these knockout mice indicated
compensatory mechanism between positive and negative
regulators at the G1/S transition and highlighted a complex
network regulating the expression and activation of these
cell cycle regulators in the progression from G1 to S phase.
For instance, mouse embryos lacking all interphase Cdks
(Cdk2, Cdk3, Cdk4, and Cdk6) undergo organogenesis
and develop up to midgestation. In these embryos, Cdk1
binds to all cyclins, resulting in the phosphorylation of the
retinoblastoma protein pRb and the expression of genes that
are regulated by E2F transcription factors [88]. Interestingly,
cyclin A ablation in fibroblasts did not aﬀect proliferation but
led to prolonged expression of cyclin E whereas its expression
is essential for cell cycle progression of hematopoietic cells
and embryonic stem cells [89]. Therefore, compensatory
mechanisms and overlapping role of Cdks exist but vary
between cell types.
The in vivo model of regenerating liver was used for cell
cycle studies since hepatocyte progression in the cell cycle
is naturally synchronous with a long lasting G1-phase. Our
group and others investigated Cdk2 and Cdk1 expression
and activity as well as cyclin A, B, E, and D1 expression
during liver regeneration [31, 90–92]. Although Cdk2 is
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Figure 6: Sequential activation of Cdk/cyclin complexes through-
out the cell cycle.
constantly expressed, Cdk1 is completely absent in resting
hepatocytes and remains undetectable up to 20 h after PH
a time corresponding to late G1 phase and G1/S transition.
In quiescent hepatocytes, Jaumot et al. [93] demonstrated
that cyclin D3 and Cdk4 were localized in cytoplasm whereas
cyclin D1 was nuclear. Low amounts of cyclin E are found
in the cytoplasm [94]. Around 13 h after PH, cyclins D3 and
Cdk4 translocate in the nucleus and significant amounts of
cyclin D1/Cdk4 and cyclin D3/Cdk4 complexes are formed
but remain inactive whereas at 24 h they are fully active. At 13
and 24 h, cyclin E is detected in both cytoplasm and nuclei.
Then, the activity of Cdk4 decreases at 28 h when cyclin D1
translocates to the nuclear matrix and the levels of cyclin
D3 diminishes. Similarly, the inactivation of Cdk2 at 28 h
is associated with a strong decrease in Cdk2 in the nuclear
fraction and a decrease of cyclin E located in the nuclei.
During this period, very low amounts of cyclin A are detected
in the nuclear fraction at 13 h after PH while following its
strong induction in S phase, cyclin A is present in both
cytoplasm and nuclei at 24 and 28 h. Therefore, the specific
nuclear localization of the complexes is associated with
their activity in liver regeneration. The maximal activity of
Cdk2 detected at 24 h comes from cyclin E/Cdk2 and cyclin
A/Cdk2 complexes whereas the activity at 28 h is mainly
attributable to the Cdk2/cyclin A heterodimer. However, the
activity of Cdk2 rapidly decreases after the peak of DNA
synthesis at 24 h.
The Cdk inhibitors (Cdki’s) are involved in cell cycle
regulation following antagonist mitogenic and antimitogenic
signals [95, 96]. Two families of Cdki’s were described:
the Ink4 family (p16Ink4a, p15Ink4b, p18Ink4c and p19Ink4d),
which specifically bind Cdk4 and its homologue Cdk6 and
the Cip/Kip family (p21Cip, p27Kip1, p27Kip2), which bind
and inhibit the activity of a wide range of Cdk/cyclin
complexes including cyclin D/Cdk4/6, cyclin E/Cdk2, and
cyclin A/Cdk2 [96]. The presence of inactive cyclin D/Cdk4
complexes during mid-G1 phase post-PH and Cyclin E/cdk2
at 28 h has led authors to investigate the modulation of
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Cdk kinase activities during rat liver regeneration. During
rat liver regeneration, p27Kip1 is associated with inactive
cyclin D/Cdk4 complexes [93]. Furthermore, Pujol et al.
[94] have demonstrated that high amounts of p27Kip1 bind
to Cdk2/cyclin E complexes in early and mid-G1 post-PH
concomitantly with low Cdk2 kinase activities. At 24 h, cor-
responding to the S phase, the amounts of p27Kip1 associated
to Cdk2/cyclin E decrease strongly while Cdk2 activity is
maximal. Conversely, the amount of p21Cip associated with
these complexes is low during the first 13 h and subsequently
increases. At 24 h low levels of both inhibitors associated
with the complexes are detected, but increase in p21Cip1 and
p27Kip1 proteins associated with Cdk2/cyclin A is observed
at 28 h after the peak of hepatocyte DNA synthesis. Albrecht
et al. [97, 98] confirmed these data and showed that expres-
sion of p21Cip1 is induced during the prereplicative phase and
is maximal after the peak of hepatocyte DNA synthesis in
mice. In contrast, p27Kip1 is present in quiescent liver and
slightly induced after PH. Immunodepletion experiments
suggested that p27Kip1 plays a role in downregulating Cdk2
activity before and after the peak of DNA replication. Inter-
estingly, study of liver regeneration in mice lacking p21Cip1
indicated a marked acceleration of hepatocyte progression
into the cell cycle. DNA synthesis, upregulation of cyclin
A and PCNA, induction of cyclin D1- and Cdk2-associated
kinase activities, and appearance of the hyperphosphorylated
retinoblastoma protein (pRb) occur earlier in the p21Cip1
knockout mice. These results demonstrate the role of p21Cip1
in the regulation of the hepatocyte progression through
G1 phase in vivo. Unexpectedly and again in contrast with
the current model of mammalian cell cycle regulation, we
observed that Cdk1 accumulates in S, G2, and M phase, in
proliferating hepatocytes and is active during both S and M
phases while one peak of Cdk2 activity is detected in S phase
only [90].
5. Involvement of Cdk1 during the S Phase
and G2/M Transition
In eukaryotic cells, chromosomal DNA replication is ensured
through periodic and tightly controlled assembly and dis-
assembly of prereplication complexes (pre-RC) loaded on
DNA replication origins [99, 100]. Inmid-late G1, the Origin
Recognition Complex (ORC) containing several subunits
associated to the proteins CDC6 and Cdt1 is responsible
for loading a replicative helicase and the minichromosome
maintenance (MCM) 2–7 subunits to form the pre-RC [100].
Interestingly, loading of the pre-RC components occurs in
a low Cdk activity period [101] while at the onset of DNA
synthesis the increasing Cdk-dependent kinase activities
trigger the MCM complex to initiate replication and the
degradation of Cdt1 to prevent reassembly of additional pre-
RC [102–104]. The induction ofMCM7 and the formation of
the pre-RC thus occur in a very narrow period of time since
in S phase, ORC1 and Cdt1 are degraded through several
mechanisms including the phosphorylation by Cdks and
downstream ubiquitination by SCFSkp2 ubiquitin Ligase
[100, 105]. These well-documented mechanisms clearly
point out the crucial role of Cdk/cyclin complexes in the
regulation of pre-RCs formation. Similarly, pre-RC are
activated by phosphorylations involving the protein kinase
Cdc7 and the Cdk2/cyclin E complex which trigger the
recruitment of Cdc45 [106], a crucial docking factor for DNA
helicase and polymerases. During S phase, the heterodimer
Cdk2/cyclin A also contributes to DNA replication [107–
109] by phosphorylating components of the replication
machinery including the Proliferating Cell Nuclear Antigen
(PCNA) and DNA polymerases. The activity of Cdk2 is thus
tightly associated with the entry into and progression in S
phase (Figure 6). Following mitosis, daughter cells receive a
single centrosome, which, like DNA, must duplicate prior
mitosis. In early S phase, centriole duplication begins and
by the late G2 two mature centrosomes have been generated
to ensure proper chromosome segregation [83]. Duplication
of centrioles is in part regulated through the G1 phase
Cdk/cyclin-dependent pRb pathway [110], and there is a
large body of evidence for the Cdk2/cyclin E involvement
in the activation by phosphorylation of crucial regulators of
centriole duplication [83].
The activity of Cdk1 associated with both A- and B-
type cyclins is required for entry and progression through
M phase in all eukaryotic cells [111]. The activity of the
Cdk1/cyclin B complex, which was the first cyclin-dependent
kinase activity detected in sea urchin and in Xenopus [112,
113], rapidly appeared to be a master regulator of the
G2/M transition, in all eukaryotic cells [111] including in
humans cells [114]. Recently, the Cdk11p58 protein kinase
was also shown to be essential for mitosis [115, 116] most
likely associated to the cyclin L’s [117]. Because the kinase
activities of Cdk2 and Cdk1 were mainly detected in G1/S
and G2/M transitions respectively, they were thought to
function independently at these two distinct periods without
functional redundancy [106, 118].
This model of cell cycle control has first been challenged
by the finding that some cancer cells proliferate despite Cdk2
inhibition [119]. Independently, there was a demonstration
that knockout mice for Cdk2 as well as for E-type Cyclins
are viable and that the cell cycle of cultured Cdk2−/−
mouse embryonic fibroblasts (MEFs) did not show major
alterations [120–122]. In addition, in the hippocampus
of Cdk2−/− mouse, the proliferation of granule neurons
of the dentate gyrus which undergo continuous renewal
throughout life, is not altered [123]. Similarly, hematopoiesis
is not aﬀected in Cdk2 knockout mice [124].These data
indicated that Cdk2/Cyclin E complexes were dispensable
for commitment to S phase. Along the same line, a Cdk1-
dependent compensatory mechanism regulating S phase
initiation and progression was also demonstrated in DT40
chicken cells lacking Cdk2 [125]. Together, these data have
led authors to propose a revised model of the cell cycle
control in which Cdk1 compensates for Cdk2 ablation by
controlling the G1/S transition, initiation of DNA replication
and centrosome duplication [118, 126]. Interestingly, it
was recently demonstrated that both Cdk1 and Cdk2 were
required for eﬃcient DNA replication inXenopus egg extracts
[127] suggesting that, at least in some nongenetically modi-
fied cell types, Cdk1 could contribute to S phase initiation
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and/or DNA replication. This idea was reinforced by the
observation that enforced expression of constitutively active
Cdk1 mutant in HeLa cells results in abnormal origin firing
and premature DNA replication in early S phase and that a
loss of Cdk1 activity compromised activation of late origins
at late S phase [103]. In this emerging picture of the cell
cycle regulation, these new data probably did not profoundly
aﬀect the roles that were initially attributed to the diﬀerent
Cdk/cyclin complexes but rather introduce the notion of
redundancy and flexibility [71, 128].
In the light of the recent findings showing compensatory
involvement of Cdk1 at the G1/S transition in Cdk2 knock-
out mice and our data showing that Cdk1 was observed
in vivo and in vitro at the G1/S transition in hepatocytes
[90, 91], we have further investigated the role of Cdk1
in normal adult rat hepatocytes in the commitment to S
phase. Cdk1 is barely detectable in quiescent hepatocytes
and during G1 phase but expressed at high levels in S phase
while Cdk2 is constantly expressed (Figure 2). Both Cdk1
and Cdk2, associated with cyclins A and/or B, are activated
during DNA replication in regenerating rat hepatocytes [33].
We demonstrated that Cdk1 activity is twice higher than
Cdk2 activity during S phase in hepatocytes. Then, knock-
down experiments of Cdk1 and/or Cdk2 were performed in
isolated hepatocytes and human foreskin fibroblasts (HFFs)
which express high and low Cdk1 levels during S phase,
respectively. SiRNA-mediated repression of Cdk1 and Cdk2
significantly decreased DNA replication in hepatocytes. In
HFFs, repression of Cdk2 significantly reduced the DNA
synthesis while repression of Cdk1 had no eﬀect on the
rate of DNA replication but, as expected, reduced the
mitotic index. In hepatocyte, the activation of Cdk1 in
early S phase is further demonstrated by showing that
hepatocytes arrested after G1/S transition prior to DNA
replication by the iron chelator O-Trensox express fully
active Cdk1 and Cdk2 [33]. Moreover, the decrease in DNA
replication after knocking-down Cdk1 or Cdk2 silencing is
not due to impaired formation of the prereplication complex
since Mcm7 is localized in the nucleus and loaded onto
chromatin. In quiescent hepatocytes, MCM7 is not expressed
but its expression becomes detectable immediately after
the mitogenic stimulation in mid-G1, almost concomitantly
with the induction of cyclin D1 and prior the Cdk-dependent
kinase activity taking place in early S phase. Thus, Cdk1
may be involved in the origin firing events downstream
the formation of replication complexes in hepatocytes, in
agreement with a recent study suggesting that cyclin A2–
Cdk1 might function as a transregulator of late origin firing
in mammals or Cdk1 is required for proper timing of origin
firing [103].
These data further support and extend the conclusion
that Cdk1 compensates for Cdk2 gene ablation in genetically
modified mice. Indeed, we have shown the involvement of
Cdk1 in S phase of normal and nongenetically modified
mammalian cells. More precisely, both Cdk1 and Cdk2
play a critical role in hepatocyte cell cycle. Consistent with
our observation, Satyanarayana et al. [129] showed that
the timing of S phase is not altered in regenerating livers
of Cdk2−/−. Interestingly, in Cdk2−/−Cdk1+/cdk2k1 mice, in
which a Cdk2 cDNA is knocked into the Cdk1 locus, similar
regenerative response and percentage of BrdU-positive cells
are obtained compared to Cdk2+/+ mice [130]. These data
indicated that Cdk2 expressed from the Cdk1 locus is able
to mimic the cell function of endogenous Cdk2 and restore
normal regeneration process and that one copy of Cdk1 is
suﬃcient for a normal liver response after PH. In addition,
Hanse et al. [131] showed that after PH most hepatocytes
enter S phase in wild-type mice whereas their number
is diminished significantly in Cdk2−/− mice. In addition,
hepatocytes isolated from livers of cdk2−/− mice respond to
mitogenic stimulation but to a lower extent than hepatocytes
coming from wild-type mice. Very recently, Diril et al. [132]
have shown that the conditional knockout of Cdk1 in adult
mouse liver does not impair S phase but results in DNA
rereplication and a strong decrease in cytokinesis associated
with an increase in Cdk2/cyclin A2 activity. The increase in
ploidy and reduced cell number suggest that Cdk1 may not
be directly involved in DNA replication but would regulate
Cdk2 activity and termination of DNA replication and play a
major role in mitosis.
Altogether, these results strengthened the conclusion
that physiological hepatocyte proliferation is dependent on
both Cdk1 and Cdk2. While Cdk1/cyclin E complexes are
not detected in normal hepatocytes, Cdk1, cyclin A, and
unexpectedly cyclin B1 are localized in the nucleus of repli-
cating cells hepatocytes and form active complexes during
S phase in regenerating hepatocytes. In most mammalian
cells, Cdk1/Cyclin B1 complexes localize in the cytoplasm
during G2 phase [133] and are activated through a positive
feedback [134] to phosphorylate cytoplasmic substrates.
Then the translocation to the nucleus triggers the breakdown
of nuclear envelops and mitosis. The absolute requirement
of cytosolic cyclin B1 during initiation of mitosis has been
proposed; however, it has also been postulated that relocating
cyclin B1 to the nucleus in S phase might compromise
entry into mitosis [135]. This would explain why the
accumulation of nuclear Cdk1/cyclin B1 complexes during
DNA replication does not trigger premature mitosis in
hepatocytes. Moreover, P-Tyr15 Cdk1 found in replicating
hepatocytes and known to be an inactive form of Cdk1
could also participate to this control. Noteworthy, Cdk1 is
active in all hepatocytes regardless of their ploidy status,
excluding a peculiar regulation or role of Cdk1 related to
the tetraploidy observed in half of adult hepatocytes in
rat. In addition, several data highlight the role of Cdk2
in hepatocyte progression and survival following acute
mitogenic stimulation [131]. Moreover, the role of Cdk2
in proper DNA repair was reported [136] and strongly
suggested that Cdk2 could be a sensor able to distinguish
between moderate and extensive DNA damage to promote
either survival or apoptosis. Several studies have reported
that Cdk1 associated with cyclin A2 or cyclin B1 was active
during S phase in proliferating hepatocytes. These reports
are in disagreement with numerous studies demonstrating
the activation and nuclear import of Cdk1 and cyclin B1 at
the G2/M transition in most cell types. Further experiments
are required to address whether Cdk1 and cyclin B1 exhibit
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a specific pattern of expression and activation during the cell
cycle of the hepatocytes and to determine their role during S
phase.
6. Extracellular Matrix Remodeling and Cdk2
Regulate Cdk1 Expression and Activation
In normal liver, adult hepatocytes quiescent and normally do
not undergo cell division but keep the ability to proliferate
in response to toxic injury and infection. In regenerating
liver, most of the hepatocytes undergo cell division while
maintaining their metabolic function and tissue architecture.
This process involved a multitude of cellular processes
including at early stage acute-phase reaction [12], induction
of proangiogenic signals [137], and an important extracellu-
lar matrix (ECM) breakdown and remodeling [138] leading
to transient changes in the liver architecture. Connective
tissue is found around the portal triads whereas reticular
fibers and small amounts of basement membrane are present
between the sinusoid endothelial cells and the hepatocytes. In
the portal areas, mainly type I, III and V collagens are found
while type IV collagen, laminin, entactin, and nidogen form
the basement membrane along the sinusoids. Fibronectin is
also present in the space of Disse [139].
Some proteins involved in the structural integrity of the
liver are also required for normal regeneration. For example,
deficiencies in connexin-32, a gap-junction protein [140],
and keratin-8, an intermediate filament forming protein
[141], lead to extended liver damage after partial hepatec-
tomy. Connexin-32 is also required for normal mitosis by
mediating cellular connections during cell division. Loss
of proteases also results in prolonged liver injury. Mice
lacking genes encoding the serine proteases urokinase-type
plasminogen activator (uPA) and tissue-type plasminogen
activator (tPA) exhibit delayed regeneration whereas the defi-
ciency of the plasminogen inhibitors leads to accelerated liver
regeneration [142, 143]. Interestingly, injection or increased
expression of collagenase in intact liver, associated with HGF
or TGFα, induces hepatocyte proliferation, suggesting that
ECM degradation could contribute to hepatocyte priming
[144]. Conversely, Issa et al. [145] observed that failure in
collagen-I degradation in mouse liver inhibits the hepatocyte
proliferation response. In rat, activation of plasminogen
to plasmin begins shortly after PH and stays pronounced
until 3–6 h. Successive inductions of mRNA levels of the
metalloproteinases (MMP)-9, MMP-2, MMP-13, MMP-14,
MMP-24, involved in matrix remodeling in both normal and
pathological processes, are observed in mouse. Moreover,
inhibitors of metalloproteinases (TIMP)-3, TIMP-4, TIMP-
1 are also upregulated. In particular, TIMP-1 expression is
induced prior the onset of DNA synthesis in rat and mouse
models [146, 147]. After PH, its activation is linked to the
hepatocyte cell cycle since experiments based on gain of
TIMP-1 function in transgenic mice result in delayed cell
cycle progression whereas loss of function in knockout mice
accelerates liver regeneration [147]. Activation of MMP-
9 after PH, mediated by plasmin or by plasmin-activated
MMP-3, is followed by activation of pro-MMP-2 in MMP-
2 probably by the membrane-type 1 MMP. In early phases
of the liver regeneration, MMP-9 is located in the immediate
periportal hepatocytes, then, its localization extends rapidly
throughout the lobule before decreasing at 72 h post-PH. In
the meantime, MMP-2 expression enhances in the hepato-
cytes at 24 and 48 h after hepatectomy [148]. Interestingly,
migration of the MMP’s staining pattern correlates with the
gradual hepatocyte progression into the cell cycle from the
periportal to the pericentral areas. This could be related to an
important regulatory mechanism for controlling cell prolif-
eration through the proteolytic maturation and/or liberation
of priming and growth factors during ECM remodeling.
In accordance, mature HGF production is delayed by 12 h
in the uPA−/− mice along with a delayed DNA synthesis.
Loss of uPA results in decreased plasmin levels responsible
for activating MMP that in turn digest the ECM and allow
release of activated growth factors like HGF fromECM [149].
Deletion of the mouse gene Timp3 results in the increase
in TNF-α converting enzyme activity (TACE), constitutive
release of TNFα and activation of TNFα-dependent signaling
in the liver. In mice lacking Timp3 gene, cyclin D1 and
PCNA expression as well as hepatocyte division occur earlier
than in wild-type mice with a shortened cell cycle. However,
these mice succumbed of liver failure by a TNFα-signaling-
dependent cell death demonstrating also the importance of
TIMP-3 in controlling TNFα bioavailability [150].
Studies performed in vitro have shown that TNFα
induces MMP-9 expression in mouse hepatocytes [151]
and that MMP-9 transcription involves activation of NF-κB
pathway [152]. Cytokine-specific regulation of MMP/TIMP
expression in hepatic stellate cells also suggests that the
initial matrix degradation during liver injury might be
enhanced by TNFα, while diminished matrix degradation
during chronic tissue injury might be due to the action
of TGF-β1 through TIMP induction [153]. Together, these
studies clearly demonstrated the importance in matrix
remodeling to promote proliferation of adult hepatocytes.
This conclusion is reinforced by the observation that normal
rat hepatocytes plated on denatured collagen I are able
to proliferate following stimulation by EGF while they do
not respond to this growth factor when plated on native
collagen I gel [154], collagen sandwich [155], or matrigel
[156]. To further address the role of the extracellular matrix
degradation to promote cell cycle entry and progression
of diﬀerentiated adult hepatocytes following stimulation by
mitogenic signals, the primary pure culture of hepatocytes
did not appear as a pertinent model since hepatocytes
progress regardless of priming factors in this model. In
addition, we had previously shown that very low amounts
of ECM were synthesized in pure culture. We therefore
used quiescent adult rat hepatocytes in coculture with liver
biliary epithelial cells (Figure 7). Indeed, asmentioned above,
hepatocytes in cocultures are stably diﬀerentiated for several
weeks and capable of extracellular matrix deposition. This
ECM located around the hepatocyte cords contains high
amounts of type III, I collagens and fibronectin as in vivo
[36]. Moreover, cytoskeleton organization of hepatocytes is
similar in coculture and in vivo with a localization of the
cytokeratins beneath of the plasma membrane [35, 157] and
bile canaliculi structures present between the hepatocytes are
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Figure 7: Upper left panel: detection of the extracellular matrix using the reticulin staining in unstimulated and EGF, TNFα or TNFα + EGF
stimulated rat hepatocytes. Upper right panel: detection of BrdU positive hepatocytes in cocultured hepatocytes 3 days after stimulation with
EGF, TNFα, HGF or combination of TNFα and EGF or HGF. Basal condition: unstimulated cells. Light blue: without fetal calf serum, dark
blue: with fetal calf serum. Lower panel: expression of Cdks and cyclins in cultured rat hepatocytes. Cyclin D1, Cdk4, Cdk2, and Cdk1 were
analyzed by western blotting. In addition, kinase activities of Cdk1 and Cdk2 were measured using histone H1 as a substrate.
also functional. Using this coculture system, we established
new conditions allowing rat hepatocytes to undergo several
proliferation waves (Figure 7) without loss of diﬀerentiation
in presence of the priming cytokine, TNFα, and growth
factors, such as HGF, EGF as observed in vivo during liver
regeneration [39].
This model of controlled induction of hepatocyte pro-
liferation has been crucial to define whether the signaling
mechanisms induced by TNFα could be linked to ECM
remodeling (Figure 7). The quantification of ECM depo-
sition detected using reticulin staining on cells stimulated
by EGF alone, TNFα/EGF, or successively by EGF and
then TNFα revealed several crucial data: (1) ECM is very
abundant in both unstimulated and EGF-treated cells,
(2) in TNFα/EGF-treated cocultures, ECM deposition is
very sparse and most fibers disappear within colonies of
proliferating hepatocytes, (3) TNFα stimulation, before or
after EGF exposure, induces ECM degradation, (4) during
prolonged TNFα/EGF stimulation, DNA synthesis decreases
concomitantly with new ECM deposition. In addition,
the phenanthroline, a specific inhibitor of MMP activities
reduces the TNFα-mediated ECM degradation resulting in
the decrease in DNA replication. Additional experiments
further demonstrated that the ECM degradation was due
to the NF-κB-mediated induction of MMP-9 expression by
TNFα [39]. Thus, ECM proteolysis controlled by TNFα
via activation of the NF-κB pathway and induction of
MMP-9 is necessary for S phase entry in hepatocytes.
This ECM remodeling signal is also required for initiating
any subsequent hepatocyte division wave in presence of
mitogen [39]. These observations have been confirmed by
Olle and coworkers using MMP-9−/− mice [158]. Indeed,
in these animals hepatic regenerative response is delayed
compared with wild-type control animals. Moreover, they
express significantly less HGF and TNFα at day 2 post-
PH corresponding to hepatocyte DNA synthesis in mice
[158]. In addition, in hepatoma cells, TNFα stimulates DNA
replication by causing release of TGFα into the culture
medium through the metalloproteinase disintegrin TACE.
Then, TGFα activates EGFR and multiple downstream
intracellular signaling cascades required for DNA replication
[159].
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Using both pure culture of hepatocytes and the coculture
model, we compared expression of cell cycle markers to
further investigate the molecular pathways involved in the
progression in late G1 phase. In unstimulated cocultures,
cyclin D1 and Cdk2 are barely detectable (Figure 7). This
pattern of expression, similar to that observed in unstimu-
lated primary pure cultures of hepatocytes, suggested that
they are blocked in G1 upstream the mitogen restriction
point. Unexpectedly, although no BrdU-positive hepatocytes
are detected in EGF-stimulated co-cultures, cyclin D1, Cdk4,
and Cdk2 accumulate in this culture condition. Interestingly,
even if Cdk2 was present, no histone H1 kinase activity
is detected (Figure 7). Therefore, EGF alone promotes the
progression beyond the mitogen restriction point in late G1
although cells arrest before S phase. Our results could be
linked to previous reports showing that cyclin E and Cdk2
are present in cells plated on denatured collagen film, while
hepatocytes plated on collagen gel do not proliferate and lack
the Cdk2 activity [154]. Moreover, both Cdk2 and Cdk1 are
active. We therefore point out a new cell cycle control in
late G1 associated with ECM deposition and overcome by
TNFα addition that triggers ECM remodeling and induction
of MMP9. Importantly, TNFα stimulation following EGF
exposition induces the expression of Cdk1 and the activation
of both Cdk2 and Cdk1 kinase activities. Altogether, our
results show that induction of Cdk1, correlating with
the hepatocyte S phase entry, requires remodeling of the
extracellular matrix and induction of the metalloproteinase
MMP9 by TNFα stimulation. They also suggest that catalytic
activation of Cdk1 may be regulated by Cdk2 kinase activity.
This led us to draw the conclusion that Cdk2 and Cdk1
would exhibit a sequential catalytic activation under the
control of extracellular signals including cytokines, growth
factors as well as extracellular matrix remodeling. TNFα–
mediated ECM remodeling is necessary for Cdk2 activity,
Cdk1 expression, G1/S transition, and completion of the cell
cycle of hepatocytes in co-cultures.
7. Conclusion
Altogether, our laboratory and others have demonstrated
the concomitant expression and activation of both Cdk1
and Cdk2 during S phase in hepatocytes and their active
contribution to the DNA replication. Finally, we show that
Cdk1 expression and activation are correlated to ECM
degradation via the involvement of the proinflammatory
cytokine TNFα. We thus identified for the first time a
new signaling pathway regulating Cdk1 expression at the
G1/S transition upon stimulation by cytokines. The peculiar
biphasic pattern of Cdk1 activity during cell cycle of normal
hepatocytes and the evenly active Cdk1 and Cdk2 during S
phase contrasts with most mammalian cell types in which
active Cdk2 is highly predominant over other Cdks in S
phase. In most cell types, the low levels of expression and
activation of Cdk1 in S phase led to the conclusion that Cdk1
and Cdk2 were functionally exclusive with specific functions
in G2/M and G1/S transitions, respectively. However, in
absence of Cdk2, Cdk1 can fully compensate for S phase
function of Cdk2 but fails to compensate for Cdk2’s DNA
repair functions in mammalian cells. Based on the data
obtained by our laboratory and others, we hypothesize
that those high levels of active Cdk1 and Cdk2 follow-
ing G1/S transition could participate to cellular defense
response following stress stimulus in controlling rapid DNA
repair and synthesis. We also showed that Cdk1 expression
and activation are correlated to ECM degradation via the
involvement of the proinflammatory cytokine TNFα. We
thus identified for the first time a new signaling pathway
regulating Cdk1 expression at the G1/S transition upon
stimulation by cytokines. It also further confirms the well-
orchestrated regulation of liver regeneration via multiple
extracellular signals and pathways. Several important ques-
tions remain unanswered. How does TNFα induce Cdk2
kinase activity? It could be hypothesized that low levels
of the Cdk inhibitor p27Kip1 following TNFα stimulation
favors activation of Cdk2/cyclin E and Cdk2/cyclin A kinase
activities. In addition, the mechanism by which TNFα
induces Cdk1 expression remains unclear. Does it involve a
transcriptional regulationmediated by unidentified signaling
pathways and transcription factors? Local remodeling of the
ECM could lead to disruption of ECM-cell communications
achieved by integrins. Through multiple protein-protein
interactions and signaling events, they could activate various
signaling cascades regulating transcriptional activities. For
example, repression of integrin-linked kinase (ILK), a cell-
ECM-adhesion component implicated in cell-ECM signaling
via the integrins, leads to enhanced cell proliferation and
hepatomegaly [160].
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